You are here

View Text Box

Providers can access this information using the query portal to HSX’s regional Clinical Data Repository or via batched reporting.  

  • HSX can provide transition-of-care tracking on a patient’s journey from suspected exposure, to lab test, to lab result, entry to the hospital, and any encounters in between or following among its region-wide participating organizations.
     
  • HSX can supplement and compliment reports for its service area on incidence and outcomes for COVID-19, and can help to coordinate regional reporting.
     
  • HSX is aggregating and reporting COVID-19 information based on these codes:
    • WHO Emergency ICD-10 Codes (starting to be used)
      • U07.1 – Lab Confirmed Diagnosis
      • U07.2 – Clinical Diagnosis
         
    •  CDC Guidance
      •  B97.29, Other coronavirus as cause of disease classified elsewhere
        • +J12.89, Other viral pneumonia
        • +J20.8, Acute bronchitis due to other specified organisms
        • +J40, Bronchitis not otherwise specified
        • +J22, Unspecified acute lower respiratory tract infection
        • +J98.8, Other specified respiratory disorders
        • +J80, Acute respiratory distress syndrome
      • Z20.828, Contact with and suspected exposure to other viral communicable diseases
      • Z03.818, Encounter for observation for suspected exposure to other biological agents ruled out
      •  B34.2, Coronavirus infection, unspecified (not specific to COVID-19) (signs & symptoms: Cough (R05), Shortness of breath (R06.02), Fever, unspecified (R50.9)).

This information — driven by EMR’s/EHR’s data and a mix of clinical and lab-confirmed codes (and seeking to include any separate mobile testing) — is refreshed daily at HSX.
 

COVID-19 Regional Distribution

Distribution of patients with COVID-19 diagnoses based on ICD10 code and/or positive lab result, by patient’s residence.  Map shows prevalence, i.e., the number of affected patients in each area divided by an estimate of the number of individuals in that area (in thousands).  Because HSX’s view of all the patients in each zip code is incomplete and varies by geography, we use the total number of people in the HSX database with encounters since 1/1/2019 in each zip code as a proxy for the actual population.  Zip codes where the number of people in the HSX database is below 1,000 are not shown, as these would produce inflated measures of prevalence.

Darker shading indicates higher concentrations of affected patients in each area.

In Philadelphia and its surrounds  in the past week, the highest numbers of new cases reported are from Jenkintow/Rydal, Cobbs Creek/Kingsessing, and North Philadelphia/Nicetown-Tioga.  Other locations of high prevalence include certain Reading-area and central New Jersey zip codes.  

 

[Note: Reports from HealthShare Exchange’s (HSX) Data Analytics and Quality department are based on trends and activity evident in data contributed by HSX provider members across the region, including parts of New Jersey, Pennsylvania, and Delaware.  Data shown come from clinical encounters (i.e., ADT – Admit, Discharge, Transfer HL7 messaging) and lab results sent to HSX directly from members’ electronic medical records (EMR) systems or from testing labs.  Results graphed on this page are through May 19, 2020, unless otherwise noted.​

COVID-19 diagnoses based on ––
• COVID-19 ICD-10 code on an outpatient, ED or inpatient encounter: B97.29, B34.2, U07.1 and U07.2 (the U codes are the CDC recommended codes starting April 1, 2020).
• Positive lab results for any version of the SARS-CoV-2 test.

These data totals above, aggregated for HSX-member healthcare entities, may vary from governmental or other organizations’ data sets, as HSX  information is collected through health information exchange and represents activity among participating facilities based on ADT feeds and thus does not fully account for ambulatory patient activity within HSX’s medical service area.]